2020
DOI: 10.1177/1751143720977278
|View full text |Cite
|
Sign up to set email alerts
|

Aerosol generation during percutaneous tracheostomy insertion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
9
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(10 citation statements)
references
References 4 publications
1
9
0
Order By: Relevance
“…Accumulating evidence demonstrates many procedures currently defined as AGPs are not intrinsically high risk for generating aerosol, and that natural patient respiratory events (such as coughing) often generate far higher levels [11][12][13][14]. Furthermore, some of those procedures that do generate aerosol (such as oesophagogastroduodenal endoscopy) only do so when they cause coughing [18].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Accumulating evidence demonstrates many procedures currently defined as AGPs are not intrinsically high risk for generating aerosol, and that natural patient respiratory events (such as coughing) often generate far higher levels [11][12][13][14]. Furthermore, some of those procedures that do generate aerosol (such as oesophagogastroduodenal endoscopy) only do so when they cause coughing [18].…”
Section: Discussionmentioning
confidence: 99%
“…Several recent studies have questioned whether these medical procedures should be classified as 'aerosol-generating' following quantitation of the aerosol produced during these patient care activities [11][12][13][14][15].…”
Section: Introductionmentioning
confidence: 99%
“…The categorisation of OGD as an AGP was not based on evidence demonstrating aerosol generation from this intervention, nor from being associated with an increased incidence of SARS-CoV-2 transmission to healthcare workers conducting the procedures. Recent work directly measuring aerosol levels in the clinical environment has questioned the validity of inclusion of several procedures defined as ‘aerosol generating’ including tracheal intubation and extubation 20 , percutaneous tracheostomy 21 and respiratory supportive treatments such as continuous positive airway pressure delivered via a facemask. 22–24 …”
Section: Introductionmentioning
confidence: 99%
“…Procedures' or better even to reassess use of the term at all [11]. This term places the emphasis of risk on the medical procedure (many of which have been demonstrated not to generate aerosol [6,[16][17][18][19]) whilst neglecting multiple factors that should be considered during the risk of assessment of any patient interaction. The risk assessment should consider the likelihood of the patient being infected with a respiratory pathogen (such as SARS-CoV-2), the proximity of the operator to the patient's respiratory tract, the duration of this proximity, the health, immune and vaccination status of the operator and the environment in which the interaction occurs.…”
Section: Discussionmentioning
confidence: 99%